Cargando…

Chemotherapy-Free Targeted Anti-BCR-ABL+ Acute Lymphoblastic Leukemia Therapy May Benefit the Heart

SIMPLE SUMMARY: Risk-adapted multiagent chemotherapy has led to a remarkable improvement in the life expectancy of patients with acute lymphoblastic leukemia (ALL). Nevertheless, in high-risk subgroups such as BCR-ABL+ ALL, relapse rates remain high without allogeneic hematopoietic stem cell transpl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kirchhoff, Hanna, Ricke-Hoch, Melanie, Wohlan, Katharina, Pietzsch, Stefan, Karsli, Ümran, Erschow, Sergej, Zweigerdt, Robert, Ganser, Arnold, Eder, Matthias, Scherr, Michaela, Hilfiker-Kleiner, Denise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870618/ https://www.ncbi.nlm.nih.gov/pubmed/35205731 http://dx.doi.org/10.3390/cancers14040983

Ejemplares similares

Optimized induction of mitochondrial apoptosis for chemotherapy-free treatment of BCR-ABL+acute lymphoblastic leukemia
por: Scherr, Michaela, et al.
Publicado: (2018)

Neuraminidase-1 promotes heart failure after ischemia/reperfusion injury by affecting cardiomyocytes and invading monocytes/macrophages
por: Heimerl, Maren, et al.
Publicado: (2020)

Anthracycline-free tumor elimination in mice leads to functional and molecular cardiac recovery from cancer-induced alterations in contrast to long-lasting doxorubicin treatment effects
por: Pietzsch, Stefan, et al.
Publicado: (2021)

Differential expression of miR-17∼92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia
por: Scherr, M, et al.
Publicado: (2014)

Stable depletion of RUNX1-ETO in Kasumi-1 cells induces expression and enhanced proteolytic activity of Cathepsin G and Neutrophil Elastase
por: Schoenherr, Caroline, et al.
Publicado: (2019)

Increased prostaglandin-D(2) in male STAT3-deficient hearts shifts cardiac progenitor cells from endothelial to white adipocyte differentiation
por: Stelling, Elisabeth, et al.
Publicado: (2020)

BCR-ABL Affects STAT5A and STAT5B Differentially
por: Schaller-Schönitz, Michael, et al.
Publicado: (2014)

Data on left ventricular expression of STAT3 and AKT in transgenic mouse models with B16F10 melanoma
por: Pietzsch, Stefan, et al.
Publicado: (2019)

Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy
por: Pfeffer, Tobias J., et al.
Publicado: (2022)

miR-125b regulates chemotaxis and survival of bone marrow derived granulocytes in vitro and in vivo
por: Lee, Chun-Wei, et al.
Publicado: (2018)

Transcriptomic classes of BCR-ABL1 lymphoblastic leukemia
por: Kim, Jaeseung C., et al.
Publicado: (2023)

Perhexiline treatment improves toxic effects of β‐adrenergic receptor stimulation in experimental peripartum cardiomyopathy
por: Pfeffer, Tobias J., et al.
Publicado: (2021)

Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia
por: Maletzke, Saskia, et al.
Publicado: (2022)

Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemia
por: Fei, Fei, et al.
Publicado: (2010)

Nilotinib treatment in mouse models of P190 Bcr/Abl lymphoblastic leukemia
por: Kaur, Pavinder, et al.
Publicado: (2007)

Environment-mediated drug resistance in Bcr/Abl-positive acute lymphoblastic leukemia
por: Feldhahn, Niklas, et al.
Publicado: (2012)

BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy
por: Cario, Gunnar, et al.
Publicado: (2020)

Role of Vitamins A and D in BCR-ABL Arf(−/−) Acute Lymphoblastic Leukemia
por: Annu, Kavya, et al.
Publicado: (2020)

Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy
por: Stapel, Britta, et al.
Publicado: (2017)

Cardiomyocytes display low mitochondrial priming and are highly resistant toward cytotoxic T‐cell killing
por: Zheng, Xiang, et al.
Publicado: (2016)

T lymphoblastic lymphoma with BCR-ABL negative chronic myeloid leukaemia: a novel association
por: Faizan, Mahwish, et al.
Publicado: (2021)

Detection of ABL1 kinase domain mutations in therapy-naïve BCR-ABL1-positive acute lymphoblastic leukemia
por: Baer, Constance, et al.
Publicado: (2021)

Impact of timely BCR-ABL1 monitoring before allogeneic stem cell transplantation among patients with BCR-ABL1-positive B-acute lymphoblastic leukemia
por: Chong, Siew Lian, et al.
Publicado: (2021)

Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy
por: Nonhoff, Justus, et al.
Publicado: (2017)

Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
por: Mian, Afsar Ali, et al.
Publicado: (2012)

A Case with Coexistence of Major and Minor BCR/ABL Fusion Transcript at Lymphoblastic Crisis of Chronic Myelogenous Leukemia in Patients with Major BCR/ABL Positivity during Chronic Phase
por: Park, Sang Hyuk, et al.
Publicado: (2013)

SFPQ-ABL1 and BCR-ABL1 use different signaling networks to drive B-cell acute lymphoblastic leukemia
por: Brown, Lauren M., et al.
Publicado: (2022)

Sphingosine kinase 2 supports the development of BCR/ABL-independent acute lymphoblastic leukemia in mice
por: Xie, Vicki, et al.
Publicado: (2018)

Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia
por: Boer, Judith M., et al.
Publicado: (2016)

BCR/ABL1-positive B-lymphoblastic Lymphoma Successfully Treated with Dasatinib-combined Chemotherapy
por: Yamada, Chika, et al.
Publicado: (2021)

Targeting BCR-ABL(+) stem/progenitor cells and BCR-ABL-T315I mutant cells by effective inhibition of the BCR-ABL-Tyr177-GRB2 complex
por: Chen, Min, et al.
Publicado: (2017)

Common genetic predisposition for heart failure and cancer
por: Pfeffer, Tobias J., et al.
Publicado: (2020)

The e8a2 fusion transcript in B lymphoblastic leukemia with BCR-ABL1 rearrangement
por: Kim, Min Jin, et al.
Publicado: (2012)

Unique amplification of BCR-ABL1 gene fusion in a case of T-cell acute lymphoblastic leukemia
por: Koka, Rima, et al.
Publicado: (2017)

Expression of the Immune Checkpoint Modulator OX40 in Acute Lymphoblastic Leukemia Is Associated with BCR-ABL Positivity()
por: Rothfelder, Kathrin, et al.
Publicado: (2018)

RUNX1 transactivates BCR‐ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia
por: Masuda, Tatsuya, et al.
Publicado: (2021)

In BCR-ABL1 Positive B-Cell Acute Lymphoblastic Leukemia, Steroid Therapy Induces Hypofibrinogenemia
por: Buzzatti, Elisa, et al.
Publicado: (2022)

Low-dose Erythropoietin reduces risk of heart failure induced by anti-cancer therapy
por: Hoch, Melanie, et al.
Publicado: (2011)

Human iPSC-Derived Cardiomyocytes of Peripartum Patients With Cardiomyopathy Reveal Aberrant Regulation of Lipid Metabolism
por: Hoes, Martijn F., et al.
Publicado: (2020)

BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
por: Sharma, Nitesh, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dkp8j0vbbv24fdo9ihmf307oun